Conexeu Sciences Inc. (CNXU) vs Rallybio Corporation (RLYB)

A side-by-side comparison of Conexeu Sciences Inc. and Rallybio Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CNXU

Conexeu Sciences Inc.

$98M

$3.66HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

RLYB

Rallybio Corporation

$91M

$17.08HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CNXU vs RLYB

growth of $100 · dividends reinvested · last 1y

CNXU -76.1% (-76.1%/yr)RLYB +9.9% (+9.9%/yr)RLYB compounded faster over this window

CNXU RLYB

Metrics side by side

Total return (annualized)

Metric	CNXU	RLYB
Total return (1Y)	N/A	271.55%
Total return CAGR (3Y)	N/A	-17.41%
Total return CAGR (5Y)	N/A	-35.80%

CNXU is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full CNXU analysis Full RLYB analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.